card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Protein Therapeutics by Immunoaffinity LC-MS: Latest Trends and Recommendations

Learn about the application of immunoaffinity LC-MS to regulated bioanalysis of biotherapeutics
Home / Insights / Protein Therapeutics by Immunoaffinity LC-MS: Latest Trends and Recommendations

Significant developments have impacted the application of immunoaffinity liquid chromatography-mass spectrometry (LC-MS) to regulated biotherapeutics. This presentation focuses on the latest LC-MS technologies and techniques that are impacting the development of protein-based drugs. Approaches taken are in line with industry trends and regulatory expectations established around bioanalysis.

What will you learn?

  • The strengths and weaknesses of LC-MS for protein bioanalysis
  • How to apply modern LC-MS technology, including nano-flow LC and high resolution mass spectrometry (HRMS)
  • Principles around holistic bioanalytical strategies for biotherapeutics


Listen to the on-demand webinar featuring this presentation here.

Authors:
Stephen Lowes, Ph.D., Senior Scientific Director, Bioanalysis and ADME Services
Barry Jones, Ph.D., Associate Director, LCMS Biologics and Biomarkers